TIRZ 5mg – Innovative research peptide inspired by Tirzepatid: Your support in the fight against obesity and insulin resistance

🧬 TIRZ 5mg – Innovative research peptide inspired by Tirzepatid: Your support in the fight against obesity and insulin resistance

What is TIRZ 5mg?

TIRZ 5mg is a modern Research peptide, inspired by a well-known molecule tirzepatidu, which combines the properties of two incretin receptor agonists: GLP-1 and GIP. It was created for scientific research on body weight regulation, glucose metabolism and modern therapies for obesity and type 2 diabetes.

⚠️ Product not intended for human consumption. It can be used for research and laboratory purposes only.

🔬 Benefits of using TIRZ 5mg in studies

1. Effective weight loss
   It reduces appetite, delays stomach emptying and helps burn fat, especially around the belly.
2. Improving blood sugar control
   It stabilizes glycemia, improves insulin sensitivity and supports its secretion.
3. Synergistic metabolic action
   The combination of GLP-1 and GIP allows for more comprehensive regulation of metabolic processes than in the case of monotherapy.
4. Long-term support
   Studies show that regular use of peptides such as tirzepatide can help reduce even 27% body weight within 18 months.

📋 Application and dosage of TIRZ 5mg – how to prepare for testing?

Package contents:

• 1 vial of 5 mg pure peptide (lyophilisate)
• Purity ≥98% (HPLC)

How to prepare the solution:

1. Add 1 ml bacteriostatic water into the peptide vial.
2. Gently swirl the vial (do not shake) until the peptide is dissolved.
3. Store in refrigerator at room temperature 2–8°C.

🧪 Who is TIRZ for (in the context of research)?

The product is ideal for use in laboratories dealing with:

• research on obesity and metabolic syndrome
• testing innovative therapies in insulin resistance
• analysis mechanisms of action of GLP-1 and GIP agonists
• modeling the influence of incretins on satiety and glucose metabolism

📚 Proven effectiveness - clinical trial results

• PMC8041915 – Efficacy of tirzepatide in reducing body weight
• PMC7610911 – Metabolic action of GLP-1 and GIP

These studies indicate high effectiveness of therapy with the use of tirzepatide analogues – up to 30% body weight reduction within 6–12 months.

📦 Storage and security

• Store in original packaging
• Store in a cool, dry place, away from light
• The product should not come into contact with skin or mucous membranes.
• Avoid use during pregnancy and breastfeeding
• Only for people with laboratory qualifications

✅ Why choose TIRZ 5mg for research?

• Action based on the latest scientific discoveries
• Tirzepatide analogue – confirmed clinical efficacy
• High purity and stability
• Possibility of precise testing of metabolic processes

🧠 Summary

TIRZ 5mg is one of the most promising research peptides in the context of fighting obesity and metabolic disorders. Thanks to the synergy of GLP-1 and GIP receptors, it is a powerful tool in research on modern metabolic therapies. Although the product is not intended for use in humans, its scientific potential is invaluable.

PepEurope

All Author Posts